Evidence map›Paper›PMID 38731401›Full record

ArticleMolecules (Basel, Switzerland)2024

Babatunji Emmanuel Oyinloye, David Ezekiel Shamaki, Emmanuel Ayodeji Agbebi, Sunday Amos Onikanni, Chukwudi Sunday Ubah, Raphael Taiwo Aruleba, Tran Nhat Phong Dao, Olutunmise Victoria Owolabi, Olajumoke Tolulope Idowu, Makhosazana Siduduzile Mathenjwa-Goqo and 3 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Computational Investigation of the Therapeutic Potential ofInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Babatunji Emmanuel OyinloyePhytomedicine, Biochemical Toxicology and Biotechnology Research Laboratories, Department of Biochemistry, College of Sciences, Afe Babalola University, PMB 5454, Ado-Ekiti 360001, Nigeria.ORCID 0000-0003-2165-7936
David Ezekiel ShamakiPhytomedicine, Biochemical Toxicology and Biotechnology Research Laboratories, Department of Biochemistry, College of Sciences, Afe Babalola University, PMB 5454, Ado-Ekiti 360001, Nigeria.
Emmanuel Ayodeji AgbebiInstitute of Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, PMB 5454, Ado-Ekiti 360001, Nigeria.ORCID 0000-0001-9258-3095
Sunday Amos OnikanniPhytomedicine, Biochemical Toxicology and Biotechnology Research Laboratories, Department of Biochemistry, College of Sciences, Afe Babalola University, PMB 5454, Ado-Ekiti 360001, Nigeria.ORCID 0000-0003-4866-8467
Chukwudi Sunday UbahDepartment of Epidemiology and Biostatistics, College of Public Health, Temple University, Philadelphia, PA 19121, USA.
Raphael Taiwo ArulebaDepartment of Physiology, East Carolina University, Greenville, NC 27834, USA.ORCID 0000-0003-0879-344X
Tran Nhat Phong DaoGraduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0002-5794-8447
Olutunmise Victoria OwolabiMedical Biochemistry Unit, College of Medicine and Health Sciences, Afe Babalola University, PMB 5454, Ado-Ekiti 360001, Nigeria.ORCID 0000-0001-5445-4209
Olajumoke Tolulope IdowuIndustrial Chemistry Unit, Department of Chemical Sciences, College of Sciences, Afe Babalola University, Ado-Ekiti 360001, Nigeria.
Makhosazana Siduduzile Mathenjwa-GoqoBiotechnology and Structural Biology (BSB) Group, Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa.
Deborah Tolulope EsanFaculty of Nursing Sciences, College of Health Sciences, Bowen University, Iwo 232102, Nigeria.ORCID 0000-0002-3896-8207
Basiru Olaitan AjiboyeInstitute of Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, PMB 5454, Ado-Ekiti 360001, Nigeria.
Olaposi Idowu OmotuyiInstitute of Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, PMB 5454, Ado-Ekiti 360001, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The burden of human schistosomiasis, a known but neglected tropical disease in Sub-Saharan Africa, has been worrisome in recent years. It is becoming increasingly difficult to tackle schistosomiasis with praziquantel, a drug known to be effective against all

Indexed as

AzadirachtaDihydroorotate DehydrogenaseMolecular Docking SimulationOxidoreductases Acting on CH-CH Group DonorsSchistosomiasisAnimalsComputer SimulationHumansMolecular Dynamics SimulationMultienzyme ComplexesNADH, NADPH OxidoreductasesPhytochemicalsPlant ExtractsPraziquantelSchistosoma mansoniSchistosomicidesDihydroorotate DehydrogenaseMultienzyme ComplexesNADH, NADPH OxidoreductasesOxidoreductases Acting on CH-CH Group DonorsPhytochemicalsPlant ExtractsPraziquantelSchistosomicidesthioredoxin glutathione reductaseAzadirachta indicadihydroorotate dehydrogenasepharmacophoreschistosomiasissimulation

Identifiers

PMID38731401
PMCPMC11084920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.